What is QNRX's earnings growth forecast for 2025-2025?
(NASDAQ: QNRX) Quoin Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Quoin Pharmaceuticals's earnings in 2025 is -$10,447,371.
In 2025, QNRX is forecast to generate -$561,993,159 in earnings, with the lowest earnings forecast at -$561,993,159 and the highest earnings forecast at -$561,993,159.
What is QNRX's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: QNRX) forecast ROE is -9,483.82%, which is considered weak.
What is QNRX's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: QNRX) Quoin Pharmaceuticals's current Earnings Per Share (EPS) is N/A. In 2025, QNRX's EPS is forecast to hit -$27.30 (min: -$27.30, max: -$27.30).
What is QNRX's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: QNRX) forecast ROA is -4,337.99%, which is lower than the forecast US Biotechnology industry average of -1.27%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.